Once‐daily ICS/LABA combined inhalers vs once‐daily LAMA
Quality of life · patients with chronic obstructive pulmonary disease
1 finding from 1 review
- Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic… 2018 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 779 participantsVery low